2000 Vol.18, N°5 - Suppl.21 - Table of contents

Bone mass in the rheumatic diseases

Guest Editors: M. Mazzantini, N.E. Lane, T. Pincus

Introduction

CER1481
2000,18,5,Suppl.21
Pg. 0001

Free to view

Bone mass in the rheumatoid diseases
M. Mazzantini, N.E. Lane, T. Pincus

Full Papers

CER1156
2000,18,5,Suppl.21
Pg. 0002-0004

Free to view

Rheumatic diseases, glucocorticoid treatment and bone mass: Recent developments
M. Mazzantini, T. Pincus, N.E. Lane

CER1157
2000,18,5,Suppl.21
Pg. 0005-0011

Free to view

Bone metabolism in rheumatoid arthritis
J.W.G. Jacobs, R.N.J. de Nijs, W.F. Lems, J.W.J. Bijlsma

CER1158
2000,18,5,Suppl.21
Pg. 0012-0015

Free to view

Bone mass in rheumatoid arthritis
E.J.J.A. Kroot, R.F.J.M. Laan

CER1159
2000,18,5,Suppl.21
Pg. 0016-0020

Free to view

Bone mass in ankylosing spondylitis
E. Toussirot, D. Wendling

CER1160
2000,18,5,Suppl.21
Pg. 0021-0026

Free to view

Bone mass and osteoarthritis
J. Dequeker, F.P. Luyten

CER1161
2000,18,5,Suppl.21
Pg. 0027-0034

Free to view

Bone mass in systemic lupus erythematosus
L. Sinigaglia, M. Varenna, L. Binelli, F. Zucchi, D. Ghiringhelli, F. Fantini

CER1162
2000,18,5,Suppl.21
Pg. 0035-0040

Free to view

The pathogenesis of glucocorticoid-induced osteoporosis
R.S. Weinstein

CER1163
2000,18,5,Suppl.21
Pg. 0041-0043

Free to view

Clinical and diagnostic features of glucocorticoid-induced osteoporosis
L.M. Buckley

CER1164
2000,18,5,Suppl.21
Pg. 0044-0048

Free to view

Calcium and vitamin D in the prevention and treatment of glucocorticoid-induced osteoporosis
J.D. Ringe, H. Faber

CER1165
2000,18,5,Suppl.21
Pg. 0049-0052

Free to view

Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis
C. Roux, M. Dougados

CER1166
2000,18,5,Suppl.21
Pg. 0053-0056

Free to view

Calcitonin in the prevention and treatment of glucocorticoid-induced osteoporosis
F. Wu, I.R. Reid

CER1167
2000,18,5,Suppl.21
Pg. 0057-0059

Free to view

Hormonal replacement therapy in the prevention and treatment of glucocorticoid-induced osteoporosis
P. Geusens

CER1168
2000,18,5,Suppl.21
Pg. 0060-0064

Free to view

Parathyroid hormone treatment for glucocorticoid-induced osteoporosis
N.E. Lane, Q. Rehman

CER1169
2000,18,5,Suppl.21
Pg. 0065-0058

Free to view

Fluoride in the prevention and treatment of glucocorticoid-induced osteoporosis
W.F. Lems, J.W.G. Jacobs, J.W.J. Bijlsma

CER1170
2000,18,5,Suppl.21
Pg. 0069-0073

Free to view

Deflazacort and bone mass
V. Lo Cascio

CER1171
2000,18,5,Suppl.21
Pg. 0074-0076

Free to view

New perspectives in the prevention and treatment of glucocorticoid-induced osteoporosis
M.L. Brandi

CER1172
2000,18,5,Suppl.21
Pg. 0079-0086

Free to view

Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis
P. Boulos, J.D. Adachi

CER1173
2000,18,5,Suppl.21
Pg. 0087-0092

Free to view

Methotrexate and bone mass
M. Mazzantini, O. Di Munno

CER1174
2000,18,5,Suppl.21
Pg. 0093-0096

Free to view

Cyclosporine and bone mass
P.N. Sambrook